Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
17-20 March, 2025
Natural Products ExpoNatural Products Expo
Not Confirmed
Not Confirmed
04-07 March, 2025
Not Confirmed
Not Confirmed
05-07 March, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
17-20 March, 2025
Natural Products ExpoNatural Products Expo
Industry Trade Show
Not Confirmed
04-07 March, 2025
Industry Trade Show
Not Confirmed
05-07 March, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/ai-drug-discovery-market-to-grow-30-cagr-to-reach-us-35-bn-by-2034-novo-lilly-bms-forge-deals
19 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/19/2983574/0/en/GigaGen-Doses-First-Patient-in-Phase-1-Trial-of-Recombinant-Polyclonal-Drug-Candidate-GIGA-2339-for-Hepatitis-B-Virus.html
03 Oct 2024
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/grifols-gigagen-garners-135m-barda-tackle-botulinum-biothreat
20 May 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/05/20/2884820/0/en/GigaGen-Doses-First-Patient-in-Phase-1-Trial-of-Anti-CTLA-4-Oncology-Drug-Candidate-GIGA-564-in-Advanced-Solid-Tumors.html
12 Dec 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/12/12/2794694/0/en/GigaGen-Receives-FDA-Clearance-of-IND-to-Begin-Phase-1-Trial-of-Oncology-Drug-Candidate-GIGA-564-in-Solid-Tumors.html
19 Oct 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/10/19/2763125/0/en/GigaGen-Granted-Expansion-of-Contract-with-US-Department-of-Defense-to-Develop-Synthetic-Human-Antibody-Treatments-for-Botulinum-Neurotoxins.html
28 Sep 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/09/28/2751133/0/en/GigaGen-Partners-with-the-National-Cancer-Institute-to-Advance-Oncology-Drug-Candidate-GIGA-564.html
ABOUT THIS PAGE